FP-1096

DB05310ExperimentalSmall molecule

FP1096 reduced the painful symptoms of endometriosis in trial subjects with very minimal side effect.

Primary indication
Investigated for use/treatment in endometriosis.Curator reviewed
Code names
FP-1096

Which companies are running trials of FP-1096, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In